Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Pasien penyakit ginjal kronis (PGK) memiliki risiko lebih tinggi untuk jatuh ke dalam frailty karena berbagai perubahan fisiologis terkait penyakit dan berisiko mengalami dampak kesehatan yang lebih buruk. Pemahaman mengenai faktor-faktor yang berhubungan dengan kejadian frailty pada pasien PGK yang menjalani hemodialisis  sangat di perlukan untuk menginformasikan pengetahuan dan mendapatkan solusi. Penelitian ini bertujuan untuk mengetahui prevalensi frailty pada pasien hemodialisis dan faktor yang berhubungan dengan terjadinya frailty pada pasien hemodialisis.Metode: Penelitian ini merupakan penelitian potong lintang dengan menggunakan data primer. Sembilan puluh satu pasien dari unit hemodialisis RSCM dari berbagai kelompok demografis disertakan dalam studi. Sampling menggunakan metode total sampling. Frailty dinilai dengan kuesioner Frailty Index 40 item. Riwayat medis diperoleh dari rekam medis RS dan dilakukan pemeriksaan laboratorium. Dilakukan uji bivariat menggunakan Chi-Square terhadap usia, jenis kelamin, lama dialisis, status gizi, adekuasi dialisis, hemoglobin, CRP, albumin, kalsium darah, fosfat darah, dan Charlson Comorbidity Index (CCI). Identifikasi faktor yang berhubungan dengan terjadinya frailty dilakukan dengan uji binary regression dengan metode backward stepwise regression.Hasil: Dua puluh enam (28,6%) pasien mengalami frailty. Faktor yang berhubungan dengan kejadian terhadap frailty pada pasien hemodialisis yaitu jenis kelamin perempuan (PR 1,064; IK 95% 1,064-1,065), skor CCI (PR 27,168; IK 95% 3,838-192,306), lama (vintage) hemodialisis (PR 1,227; IK 95% 1,226-1,227), hemoglobin (PR 3,099; IK 95% 1,325-7,254), albumin (PR 1,387; IK 95% 1,386-1,388), CRP (PR 1,432; IK 95% 1,431-1,433), dan fosfat (PR 1,110; IK 95% 1,110-1,111).Kesimpulan: Prevalensi frailty pada populasi studi ini yaitu 28,6%. Jenis kelamin perempuan, peningkatan skor CCI, lama (vintage) hemodialisis, anemia, hipoalbuminemia, dan fosfat yang rendah ditemukan sebagai faktor yang berhubungan secara signifikan  terhadap kejadian frailty pada pasien hemodialisis di RSCM.

---

Background: Patients with chronic kidney disease (CKD) have a higher risk of falling into frailty due to various physiological changes related to the disease and are at risk for worse health impacts. Understanding the factors that correlate with the incidence of frailty in CKD patients undergoing hemodialysis is needed to inform knowledge and obtain solutions. This study aims to determine the prevalence of frailty in hemodialysis patients and predictors of frailty in hemodialysis patients.

Methods: This study is a cross-sectional study using primary data. Ninety-one patients from the RSCM hemodialysis unit from various demographic groups were included in the study. Sampling using the total sampling method. Frailty is assessed with a 40-item Frailty Index questionnaire. Medical history was obtained from hospital medical records, and laboratory examinations were carried out. A bivariate test using Chi-Square was performed on age, sex, duration of dialysis, nutritional status, dialysis adequacy, hemoglobin, CRP, albumin, blood calcium, blood phosphate, and the Charlson Comorbidity Index (CCI). The binary regression test with the backward stepwise regression method identifies factors associated with frailty.

Results: Twenty-six (28.6%) patients experienced frailty. Factors related to the incidence of frailty in hemodialysis patients were female gender (PR 1.064; 95% CI 1.064-1.065), CCI score (PR 27.168; 95% CI 3.838-192.306), duration (vintage) of hemodialysis (PR 1.227; 95% CI 1.226-1.227), anemia (PR 3.099; 95% CI 1.325-7.254), albumin (PR 1.387; 95% CI 1.386-1.388), CRP (PR 1.432; 95% CI 1.431-1.433), and phosphate (PR 1.110; CI 95% 1.110-1.111).

Conclusion: The prevalence of frailty in this study population is 28.6%. Female gender increased CCI score, old (vintage) hemodialysis, anemia, hypoalbuminemia, and low phosphate were factors significantly related to the incidence of frailty in hemodialysis patients at RSCM."

"Latar Belakang: Meningkatnva populasi usia laniut. masalah kesehatan pada kelompok usia tersebut juga meningkat. Salah satu masalah kesehatan vane sering dijumpai adalah inkontinensia urin tine sires (IUS). Beberapa nenelitian telah dilakukan untuk melihat faktor- faktor risiko terjadinva IUS, tetapi hasilnva tidak konsisten.Tuiuan: Mengetahui hubungan antara usia, riwayat cara persalinan, jumlah persalinan lama menopause dan IMT dengan IUS pada perempuan usia laniut di RSCM Jakarta.Metodologi: Disain penelitian potong-lintang. Subyek pada perempuan >60 tahun yang memenuhi kriteria inklusi. Inkontinensia Urin tine Sires dinilai dari anamnesis, pemeriksaan fisik serta pemeriksaan kontraksi vagina dengan nerineometri.Hasil: Didapatkan hasil 35 kasus dan 47 kontrol. Subyek penelitian dengan usia >75 tahun didapatkan 8 (53.3%) IUS riwayat cara persalinan mengalami tindakan didapatkan 18 150.0%) IUS. jumlah persalinan lebih dari 2 kali didapatkan 30 (43,5%) IUS lama menopause lebih dari 7 tahun didapatkan 35 (45,5%) IUS, IMT ~ 26 didapatkan 14 (58.3%) IUS. Dilakukan analisis bivariat didapatkan hasil antara usia dan IUS dengan OR 1.69 (IK 95% 0.55 - 5.22).. antara riwavat cara persalinan dan IUS dengan OR 1,71 (TTY 95% 0.70 ? 4.14) antara iumlah persalinan dan MS dengan OR 1.23 (IK 95% 0.37 - 4.15). antara IMT > 26 dan IUS dengan OR 2.47 (IK 95% 0,93 - 6.52). Lama menopause tidak dapat dianalisis karena tidak didapatkan lama menopause < 7 tahun harus mengalami IUS. Seluruh variabel hasil analisis bivariat vane memiliki p mendekati 0.25 diikutsertakan dalam analisis multivariat. Setelah dilakukan analisis multivariat dengan regresi logistik didapatkan hanva IMT vane tampaknva berhubunsan denaan IUS (OR 2.9911K 95% 1.07-8.361)Simpulan: Indeks massa tubuh merunakan faktor risiko teriadinva IUS.

---

Background: The increase of elderly nonulation leads to the increase of health problems among those who belongs to this population. Stress urinary incontinence (SUI) is one of many problems which is frequently found. Several studies have been carried out to detect risk factors for SUI. but the results were still inconsistent.Objective: To assess the relationship between age. types of delivery. Parity, menopausal period, and BM1 with SU1 in elderly women at Cipto Mangunkusumo Hospital, Jakarta.Method: A cross-sectional study of elderly women > 60 years who met the inclusion criteria. SUI was evaluated from interviews. physical examinations and vaginal contractions measured with a perineometer.Results: This study comprised 35 cases and 47 controls. SUI were detected in 8 (53.3%) of subjects who were > 75 years, in 18 (50.0%) of those who had intervention during delivery. in 30 (43,5%) of those who had parity > 2. in 35 (45.5%) of those who had had menopause > 7 years. and in 14 (58.3%) of those with BMI > 26. Bivariate analyses were performed and the results are OR 1,69 (95% CI 0.55-5.22) between age and SUL _ OR 1.71 (95% CI 0.70 - 4.14) between tunes of delivery and SUL OR L23 (95% CI 0,37 - 4.15) between parity > 2 and SU1. OR 2.47 (95% CI 0,93 - 6.521 between BM1 > 26 and Slll, Menopausal period could not be analyzed because no subjects who had less than 7 year - period of menopause was found to have SUI. Variables which had p close to 0.25 in bivariate analyses were measured in multivariate analyses with logistic regression. Those variables were types of delivery and BMI. As a result BMI was the only variable which was related to SUI (OR 2.99[95% CI 1,07-8,36 ).Conclusion: BM1 is a risk factor for SUI"

"ABSTRAK Latar Belakang: Kematian pada Penyakit Jantung Koroner (PJK) terutama akibat tindakan revaskularisasi yang tertunda atau lesi koroner kompleks yang biasanyalebih buruk pada populasi pasien PGK. Skor Modified ACEF merupakan sebuahperangkat yang memiliki peran penting dalam prognosis mortalitas PJK. SkormACEF belum pernah digunakan untuk mengevaluasi kompleksitas lesi koroner.Informasi tersebut berguna dalam menentukan prioritas tindakan angiografikoroner. Tujuan: Mendapatkan nilai diagnostik dan titik potong skor mACEF sebagaiprediktor kompleksitas lesi koroner pada pasien PGK stadium 3 dan 4 yangmengalami sindrom koroner akut (SKA). Metode: Penelitian ini merupakan uji diagnostik secara retrospektif terhadap 179subjek PGK stadium 3 dan 4 yang mengalami SKA yang dirawat di ICCU RSCMtahun 2012 hingga 2014. Analisis titik potong skor mACEF dilakukan denganmenggunakan Receiver Operating Characteristic (ROC) curves dengan intervalkepercayaan (IK) sebesar 95%. Akurasi diagnostik skor mACEF dinilai dengancara menghitung sensitivitas, spesifisitas, RKP, dan RKN. Hasil: Titik potong skor mACEF yang optimal adalah 2,288 dengan sensitivitas90,9%, spesifisitas 63,7%, RKP 2,5, RKN 0,14 dan prevalens 55,3%. Kesimpulan: Titik potong yang optimal skor mACEF pada populasi pasien PGKstadium 3 dan 4 yang mengalami SKA adalah 2,288. Akurasi diagnostik skor mACEF dinilai baik.ABSTRACT Background: Cardiovascular disease is one of the main causes of death mainlydue to delayed revascularization or complex coronary lesions which are usuallyworse in CKD patients. Modified ACEF (mACEF) score is well established indetermining cardiovascular mortality of patients undergoing revascularizationtherapy and has never been used to evaluate the complexity of coronary lesionsbefore. mACEF score?s potential as a diagnostic tool needs to be evaluated to helpstratify patients eligible for coronary angiography. Aim: To evaluate mACEF score?s diagnostic value and cut-off point as apredictor of coronary lesion complexity in patients with CKD stages 3 and 4 withACS. Methods: This study is a diagnostic test conducted retrospectively involving 179subjects with CKD stages 3 and 4 with ACS admitted to ICCU RSCM from 2012to 2014. Cut-off analysis was performed using ROC curve with confidenceintervals (CI) of 95% and diagnostic accuracy of mACEF was analyzed togenerate sensitivity, specificity, LR+, and LR-. Result: The optimal cut-off point for mACEF score was 2,288 with sensitivity of90,9%, specificity 63,7%, LR+ 2,5, LR- 0,14, and prevalence of 55,3%. Conclusion: mACEF score has a good diagnostic accuracy in subjects with CKD stage 3 and 4 with ACS with optimal cut-off point of 2,288, respectively.;Background: Cardiovascular disease is one of the main causes of death mainlydue to delayed revascularization or complex coronary lesions which are usuallyworse in CKD patients. Modified ACEF (mACEF) score is well established indetermining cardiovascular mortality of patients undergoing revascularizationtherapy and has never been used to evaluate the complexity of coronary lesionsbefore. mACEF score?s potential as a diagnostic tool needs to be evaluated to helpstratify patients eligible for coronary angiography. Aim: To evaluate mACEF score?s diagnostic value and cut-off point as apredictor of coronary lesion complexity in patients with CKD stages 3 and 4 withACS. Methods: This study is a diagnostic test conducted retrospectively involving 179subjects with CKD stages 3 and 4 with ACS admitted to ICCU RSCM from 2012to 2014. Cut-off analysis was performed using ROC curve with confidenceintervals (CI) of 95% and diagnostic accuracy of mACEF was analyzed togenerate sensitivity, specificity, LR+, and LR-. Result: The optimal cut-off point for mACEF score was 2,288 with sensitivity of90,9%, specificity 63,7%, LR+ 2,5, LR- 0,14, and prevalence of 55,3%. Conclusion: mACEF score has a good diagnostic accuracy in subjects with CKD stage 3 and 4 with ACS with optimal cut-off point of 2,288, respectively.;Background: Cardiovascular disease is one of the main causes of death mainlydue to delayed revascularization or complex coronary lesions which are usuallyworse in CKD patients. Modified ACEF (mACEF) score is well established indetermining cardiovascular mortality of patients undergoing revascularizationtherapy and has never been used to evaluate the complexity of coronary lesionsbefore. mACEF score?s potential as a diagnostic tool needs to be evaluated to helpstratify patients eligible for coronary angiography. Aim: To evaluate mACEF score?s diagnostic value and cut-off point as apredictor of coronary lesion complexity in patients with CKD stages 3 and 4 withACS. Methods: This study is a diagnostic test conducted retrospectively involving 179subjects with CKD stages 3 and 4 with ACS admitted to ICCU RSCM from 2012to 2014. Cut-off analysis was performed using ROC curve with confidenceintervals (CI) of 95% and diagnostic accuracy of mACEF was analyzed togenerate sensitivity, specificity, LR+, and LR-. Result: The optimal cut-off point for mACEF score was 2,288 with sensitivity of90,9%, specificity 63,7%, LR+ 2,5, LR- 0,14, and prevalence of 55,3%. Conclusion: mACEF score has a good diagnostic accuracy in subjects with CKD stage 3 and 4 with ACS with optimal cut-off point of 2,288, respectively.;Background: Cardiovascular disease is one of the main causes of death mainlydue to delayed revascularization or complex coronary lesions which are usuallyworse in CKD patients. Modified ACEF (mACEF) score is well established indetermining cardiovascular mortality of patients undergoing revascularizationtherapy and has never been used to evaluate the complexity of coronary lesionsbefore. mACEF score?s potential as a diagnostic tool needs to be evaluated to helpstratify patients eligible for coronary angiography. Aim: To evaluate mACEF score?s diagnostic value and cut-off point as apredictor of coronary lesion complexity in patients with CKD stages 3 and 4 withACS. Methods: This study is a diagnostic test conducted retrospectively involving 179subjects with CKD stages 3 and 4 with ACS admitted to ICCU RSCM from 2012to 2014. Cut-off analysis was performed using ROC curve with confidenceintervals (CI) of 95% and diagnostic accuracy of mACEF was analyzed togenerate sensitivity, specificity, LR+, and LR-. Result: The optimal cut-off point for mACEF score was 2,288 with sensitivity of90,9%, specificity 63,7%, LR+ 2,5, LR- 0,14, and prevalence of 55,3%. Conclusion: mACEF score has a good diagnostic accuracy in subjects with CKD stage 3 and 4 with ACS with optimal cut-off point of 2,288, respectively."

"Latar Belakang : Kejadian AKI di unit perawatan intensif berhubungan dengan peningkatan mortalitas, morbiditas pasca AKI dan biaya perawatan tinggi. Penelitian mengenai faktor-faktor yang berhubungan dengan mortalitas pasien AKI di unit perawatan intensif di Indonesia khususnya RSUPN dr. Cipto Mangungkusumo belum pernah dilakukan.Tujuan: Mengetahui prevalensi AKI, angka mortalitas pasien AKI, dan faktor- faktor yang berhubungan dengan peningkatan mortalitas pasien AKI di unit perawatan intensif di ICU RSUPN dr. Cipto Mangunkusumo.Metode : Penelitian kohort retrospektif terhadap seluruh AKI di unit perawatan intensif di RSUPN Cipto Mangunkusumo periode Januari 2015 ndash; Desember 2016. Dilakukan analisis hubungan bivariat saampai dengan multvariat dengan STATA Statistics 15.0 antara faktor usia >60 tahun, sepsis, ventilator, durasi ventilator, dialisis, oligoanuria, dan skor APACHE II saat admisi dengan mortalitas. Hasil : Prevalensi pasien AKI di unit perawatan intensif didapatkan 12,25 675 dari 5511 subjek dan sebanyak 220 subjek 32,59 dari 675 subjek yang dianalisis meninggal di unit perawatan intensif. Faktor-faktor yang berhubungan dengan peningkatan mortalitas pada analisis multivariat adalah sepsis OR 6,174; IK95 3,116-12,233 , oligoanuria OR 4,173; IK95 2,104-8,274 , ventilator OR 3,085; IK95 1,348-7,057 , skor APACHE II saat admisi 1/2 [OR 1,597; IK95 1,154-2,209], dan durasi ventilator OR 1,062; IK95 1,012-1,114 . Simpulan : Prevalensi pasien AKI dan angka mortalitasnya di unit perawatan intensif RSUPN dr. Cipto Mangunkusumo didapatkan sebesar 12,25 dan 32,59 . Sepsis, oligoanuria, ventilator, skor APACHE II saat admisi 1/2, dan durasi ventilator merupakan faktor-faktor yang berhubungan bermakna dengan peningkatan mortalitas pasien AKI di unit perawatan intensif. Kata Kunci : Acute Kidney Injury, Faktor Risiko, Mortalitas, Unit Perawatan Intensif

---

Background Acute kidney Injury AKI in ICU associated with increased mortality rate, morbidity post AKI, and high health care cost. There is no previous study about factors associated with mortality of AKI patients in ICU in Indonesia, especially at dr. Cipto Mangunkusumo National Central General Hospital.Aim To identify prevalence, mortality rate, and factors associated with mortality of AKI patients in ICU.Method This is a retrospective cohort study. Data were obtained from all of medical records of AKI patients period January 2015 until December 2016 in ICU at Cipto Mangunkusumo hospital. Association of risk factors age 60 years old, sepsis, ventilator, duration of ventilator, oligoanuria, and APACHE II score at admission and mortality will be analyzed using STATA Statistics 15.0. Results AKI prevalence in ICU was 12,25 675 subjects from total 5511 subjects . A total of 220 subjects out of 675 subjects AKI died at ICU. Sepsis OR 6,174 95 CI 3,116 12,233 , oligoanuria OR 4,173 95 CI 2,104 8,274 , ventilator OR 3,085 95 CI 1,348 7,057 , APACHE II score at admission 1 2 OR 1,597 95 CI 1,154 2,209 , and duration of ventilator OR 1,062 95 CI 1,012 1,114 . were significant factors associated with mortality of AKI patients in ICU. Conclusion AKI prevalence and mortality rate in ICU at dr. Cipto Mangunkusumo National Central General Hospital were 12,25 and 32,59 . Sepsis, oligoanuria, ventilator, APACHE II score at admission 1 2, and duration of ventilator were significant factors associated with mortality of AKI patients in ICU. Keywords Acute Kidney Injury, Intensive Care Unit, Mortality, Risk Factor "

"Latar Belakang. Hemodialisis (HD) menjadi pilihan utama terapi pengganti ginjal di Indonesia. Pada tahun 2016, Indonesia memiliki angka mortalitas satu tahun pasien dengan penyakit ginjal kronik (PGK) yang diterapi dengan HD (PGK-HD) lebih tinggi dibandingkan dengan negara lain. Saat ini, Indonesia belum memiliki banyak data terkait insidens dan faktor-faktor yang memengaruhi mortalitas pasien HD kronik.Tujuan. Mengetahui insidens dan faktor-faktor yang memengaruhi mortalitas satu tahun pasien HD kronik.Metode. Penelitian dilakukan dengan desain studi kohort prospektif di Rumah Sakit Dr. Cipto Mangunkusumo (RSCM) sejak 2020 hingga Desember 2021 dengan mengikuti 193 pasien yang masih hidup setelah tiga bulan dilakukan HD inisiasi. Pasien kemudian diobservasi selama sembilan bulan untuk mengetahui insidens mortalitas satu tahun dan faktor-faktor yang berkaitan. Data dianalisis menggunakan analisis bivariat diikuti dengan analisis multivariat cox regresi untuk mengetahui faktor-faktor yang memengaruhi mortalitas.Hasil. Rerata usia pasien penelitian adalah 52 tahun dan etiologi terbanyak pasien PGK-HD yaitu diabetes melitus (DM). Selama observasi, terdapat tiga pasien loss to follow up, dan terdapat 55 pasien meninggal. Insidens satu tahun mortalitas pada penelitian ini adalah 28,49% (IK 95% 22,25-35,42%). Setelah dilakukan analisis multivariat pada penelitian ini didapatkan tiga variabel yang secara signifikan memengaruhi mortalitas yaitu interdialytic weight gain (IDWG) ≥5% (OR 3,58, IK 95% 1,16-10,91), kadar hemoglobin <10 g/dL (OR 3,4, IK 95% 1,79-7,15), dan serum kalsium <8,5 mg/dL (OR 3,79, IK 95% 1,75-8,23).Kesimpulan. Insidens mortalitas satu tahun pasien HD kronik sebesar 28,49%. IDWG ≥5%, kadar hemoglobin <10 g/dL, dan serum kalsium <8,5 mg/dL merupakan faktor-faktor yang memengaruhi mortalitas satu tahun.

---

Background. Hemodialysis (HD) is the main kidney replacement therapy in Indonesia. In 2016, Indonesia had a higher one-year mortality rate of chronic kidney disease (CKD) patients treated with hemodialysis (CKD-HD) compared to other countries. Currently, HD centers in Indonesia lack data related to the incidence and factors related to mortality in CKD-HD patients.

Aims. To determine the incidence and factors related to one-year mortality in Chronic HD patients.

Methods. This prospective cohort study was conducted at Dr. Cipto Mangunkusumo Hospital (RSCM) from January 2020 to December 2021, following 193 patients who survived three months after initial dialysis. Patients were observed for nine months to know the one-year mortality incidence and related factors. The data were analyzed using bivariate analysis followed by multivariate cox regression analysis to review factors related to mortality.

Results. The mean age was 52 years-old and the most common etiology of CKD-HD was diabetes mellitus (DM). During follow-up, three patients dropped out due to loss to follow up and 55 patients died. One-year mortality incidence was 28.49% (95% CI 22,25-35,42%) in this study. After multivariate analyses, we found three significant variables for one-year mortality: interdialytic weight gain (IDWG) ≥5% (OR: 3.58, 95% CI: 1.16.88-10.91), hemoglobin level <10 g/dL variables, (OR: 3.4, 95%CI 1.79-7.15), and calcium serum <8.5 mg/dL (OR: 3,79, 95% CI 1.75-8.23).  

Conclusion. The incidence of one-year mortality in CKD-HD patients was 28.49%. IDWG ≥5%, hemoglobin <10 g/dL, and calcium serum <8.5 mg/dL are significant factors related to one-year mortality."

"Latar Belakang: Variabilitas hemoglobin (var-Hb) merupakan suatu fenomena fluktuasi kadar Hb dalam satuan waktu tertentu yang dialami oleh pasien penyakit ginjal kronikyang menjalani hemodialisis rutin (PGK-HD).Var-Hb telah diketahui sebagai prediktor independen luaran klinis buruk. Namun,faktor-faktor yang mempengaruhinya belum banyak diketahui. Tujuan: Mengetahui besaran proporsi var-Hb pada pasien PGK-HD di Indonesia dan faktor-faktor yang mempengaruhinya. Metode: Penelitian ini merupakan studi kohort prospektif yang melibatkan pasien GGK-HD berusia ≥18 tahun di Unit Hemodialisis RSCM. Faktor-faktor yang dinilai saat awal ialah kadar Hb, reticulocyte-hemoglobin equivalent(RET-He), albumin, fosfatase alkali, dan C-reactive protein (CRP)serum, serta adekuasi dialisis (Kt/V). Adanya perdarahan saluran cerna(termasuk darah samar feses), dosis erythropoietin-stimulating agent(ESA)dan zat besi, serta kejadian transfusi darah akan dicatat. Kadar Hb kemudian diperiksa setiap 4 minggu hingga 24 minggu pengamatan. Var-Hb dinilai dengan standar deviasi residual dan nilai ≥1,0dianggap sebagai var-Hb tinggi. Uji hipotesis dilakukan dengan uji bivariat sesuai jenis data, dilanjutkan dengan analisis multivariat menggunakan uji regresi logistikmultipel. Hasil: Sejumlah 127 subyek (rerata[SD]usia 49,06[15,1], perempuan 52%, rerata[SD]kadar Hb 9,75[1,00]g/dL) diikutsertakan dalam analisis. Proporsi subyek dengan var-Hb tinggi ialah 47,24%. Berdasarkan analisis bivariat dan multivariat, faktor yang mempengaruhi var-Hb adalah kadar RET-He(p=0,004), dosis ESA (p=0,032), dan kejadian transfusi darah (adjustedOR6,967, IK95% 2,74-17,71;p<0,001). Kesimpulan: Proporsi pasien PGK-HD di Indonesia yang memiliki var-Hb tinggi ialah 47,24%(IK95% 38,3-56,3%). Faktor-faktor yang mempengaruhi var-Hb ialah kadar RET-He,dosis ESA, dan kejadian transfusi darah.

---

Background: Hemoglobinvariability(Hb-var) is a phenomenon of Hb fluctuation during a course of time that is frequently observed in chronic kidney disease on hemodialysis (CKD-HD)patients. Hb-varis now recognized asapredictor of poor clinical outcomes. However, factors that influence the Hb-var are not well understood.Objectives.This study was aimedto measure the proportion of Hb-var in CKD-HD patients in Indonesia and identify factors associated. Methods: This was a prospective cohort study involving CKD-HD patients aged ≥18 years old in Hemodialysis Unit in RSCM. Factors identified at baseline were serum levels of Hb,reticulocyte-hemoglobin equivalent (RET-He), albumin,alkalinephosphatase, C-reactive protein (CRP), and dialysis adequacy (Kt/V). Hb level was measured every 4 weeks until 24weeks of follow up. Any evidence of gastrointestinal bleeding (including occult blood feces), erythropoietin-stimulating agent (ESA) dosage, and blood transfusion werealsonoted. Hb-var was calculatedas the residual standardofdeviation, and value ≥1.0 was considered as high.Hypothesis testing was performed by bivariate analysis, thencontinued with multivariateanalysis using multiple regression logistic test. Results: As 127 subjects (mean[SD]of age 49.06[15.1], female 52%, mean[SD]of Hb 9.75[1.00]g/dL) were included in the analysis. The proportion of subjects with high Hb-var were 47.24%. According to bivariate and multivariate analysis, factors that determined Hb-var were RET-Helevels (p=0.004), ESA dosage (p=0.032), and blood transfusion (adjustedOR 6.967, 95%CI2.74-17.71,p<0.001). Conclusion: Theproportion of CKD-HD patients in Indonesia with high Hb-var was47.24% (95%CI 38.3-56.3%). Factors that determined Hb-var wereRET-Helevels, ESA dosage, and blood transfusion."

"Gangguan metabolisme mineral dan tulang pada penyakit ginjal kronik (GMT-PGK) merupakan salah satu komplikasi yang ditemukan pada pasien PGK yang menjalani hemodialisis (PGK-HD). Manifestasi GMT-PGK dapat merupakan kelainan sistemik ataupun hanya ditemukan di tulang yang disebut sebagai renal osteodystrophy(ROD). Risiko kematian akibat GMT-PGK mencapai 17,5%. Di Indonesia, pemeriksaan penanda tulang terkait GMT-PGK belum secara rutin dikerjakan karena belum tercakup dalam pembiayaan Jaminan Kesehatan Nasional (JKN). Tujuan penelitian ini menganalisis profil kalsium, fosfat, PTH, dan vitamin D 25(OH) pada pasien PGK-HD. Penelitian ini merupakan studi potong lintang yang melibatkan 124 pasien hemodialisis rutin di Unit Hemodialisis RS Cipto Mangunkusumo (RSCM) yang berlangsung pada bulan Juni sampai Oktober 2022. Penelitian ini menggunakan data sekunder dari semua pasien hemodialisis yang memiliki data jenis kelamin, usia, durasi HD, fosfat, kalsium total, vitamin D 25(OH), dan PTH. Profil parameter tulang di dominasi turnover tinggi (75,8%), normokalsemia (78%), hiperfosfatemia (57,3%), dan status defisiensi vitamin D (82,3%). Pada penelitian ini didapatkan korelasi hanya pada parameter durasi HD dan PTH. Profil kelainan tulang berdasarkan penelitian ini lebih didominansi kelainan turnover tinggi sehingga dapat menjadi dasar untuk pemberian suplementasi analog vitamin D dan atau kalsimimetik dalam pengendalian peningkatan PTH pada pasien HD. Hiperfosfatemia masih mendominasi proporsi pasien HD sehingga tatalaksana terhadap hiperfosfatemia perlu lebih ditingkatkan dan disarankan untuk pemeriksaan berkala.

---

Chronic kidney disease–mineral and bone disorder (CKD-MBD) is one of the complications found in CKD patients undergoing hemodialysis (CKD-HD). Manifestations of CKD-MBD can be a systemic disorder or only found in the bone which is known as renal osteodystrophy (ROD). The risk of death from CKD-MBD reaches 17.5%. In Indonesia, examination of bone markers related to CKD-MBD has not been routinely carried out because it has not been covered by the National Health Insurance financing. The aim of this study was to analyze the profile of calcium, phosphate, PTH, and vitamin D 25(OH) in patients with chronic kidney disease undergoing routine hemodialysis. This research is a cross-sectional study involving 124 routine hemodialysis patients at the Hemodialysis Unit of Cipto Mangunkusumo Hospital (RSCM) which took place from June to October 2022. This study used secondary data from all hemodialysis patients who had data on gender, age, duration of HD, phosphate, total calcium, vitamin D 25(OH), and PTH. Bone parameter profile was dominated by high turnover (75.8%), normocalcemia (78%), hyperphosphatemia (57.3%), and vitamin D deficiency status (82.3%). In this study, correlation was found only on the HD and PTH duration parameters. The profile of bone abnormalities based on this study is more dominated by high turnover disorders so it can be a basis for administering supplementation of vitamin D analogues and or calcimimetics in controlling increased PTH in HD patients. Hyperphosphatemia still dominates the proportion of HD patients so that the management of hyperphosphatemia needs to be further improved and periodic checks are recommended."

"Defisiensi besi pada pasien penyakit ginjal kronis dengan hemodialisis (PGK-HD) merupakan penyebab terapi erythropoietin-stimulating agent (ESA) menjadi tidak responsif. Soluble transferrin receptor (sTfR) merupakan marker evaluasi status besi serta respons eritropoiesis yang tidak dipengaruhi inflamasi. Indeks sTfR (rasio sTfR/log feritin) diperkirakan dapat meningkatkan performa sTfR. Tujuan penelitian adalah mengevaluasi performa diagnostik sTfR dan indeks sTfR dalam tatalaksana anemia defisiensi besi pada PGK-HD. Penelitian merupakan studi potong lintang yang melibatkan 127 pasien PGK-HD di Unit Hemodialisis RS Cipto Mangunkusumo pada bulan Agustus-September 2018. Setiap subjek diperiksakan sTfR, indeks sTfR, marker besi, feritin, reticulocyte hemoglobin equivalent (RET-He), serta darah perifer lengkap. Saturasi transferin (TSAT) dan RET-He digunakan sebagai baku emas. Uji diagnostik menggunakan Chi Square dan kurva receiver operating characteristic (ROC). Pada penelitian ini didapatkan titik potong sTfR 2,71 mg/L (sensitivitas 83,3%, spesifisitas 56,5%) dan titik potong indeks sTfR 1,39 (sensitivitas 76,2%, spesifisitas 70,6%). Parameter sTfR dapat bermanfaat sebagai skrining dalam penentuan status besi serta respon eritropoiesis pada pasien PGK-HD. Tata laksana terapi besi yang adekuat akan membuat terapi ESA menjadi efektif, sehingga anemia dapat teratasi, dan kualitas hidup pasien membaik.

---

Iron deficiency in patients with chronic kidney disease and hemodialysis (CKD-HD) can cause unresponsiveness to erythropoietin-stimulating agent (ESA). Soluble transferrin receptor (sTfR) is a potential marker to evaluate iron status and erythropoiesis response, that’s not influenced by inflammation. The sTfR index (sTfR/log ferritin ratio) has been proposed could increase the diagnostic efficacy than sTfR alone. We evaluated the diagnostic performance of sTfR and sTfR index for management of iron deficiency in CKD-HD. This cross-sectional study was conducted at Cipto Mangunkusumo Hospital, Indonesia from August-September 2018, involving 127 CKD-HD patients. The sTfR level, sTfR index (sTfR/log ferritin), iron status, ferritin level, reticulocyte hemoglobin equivalent (RET-He), and complete blood count were assessed. Transferrin saturation (TSAT) and RET-He were used as references. Diagnostic tests were analyzed using the chi-square test and receiver operating characteristic curve analysis. We identified sTfR cutoff of 2.71 mg/L (sensitivity 83.3%, specificity 56.5%) and sTfR index cutoff of 1.39 (sensitivity 76.2%, specificity 70.6%). The sTfR might be useful as a screening parameter to evaluate iron status and erythropoietin response in CKD-HD patients. Appropriate iron therapy will make ESA therapy more effective, which will help to overcome anemia, and finally will improve the quality of life of CKD-HD patients.

 

"

"ABSTRAKLatar Belakang. Mortalitas pasien yang menjalani hemodialisis (HD) paling tinggi pada tigabulan pertama. Data mengenai insidens dan prediktor mortalitas dini pada pasien HD sangatterbatas. Suatu model prediksi dapat menjadi alat bantu yang sederhana untuk mengetahuipasien yang berisiko tinggi sehingga pada akhirnya upaya pencegahan dapat dilakukan.Tujuan. Mengetahui insidens dan prediktor mortalitas 3 bulan pada pasien hemodialisis barudan membuat suatu model prediksi.Metode. Penelitian dengan disain kohort retrospektif terhadap 246 pasien PGTA yang barumenjalani HD di Unit HD RSCM antara Januari 2011-Januari 2012. Dilakukan analisis chisquareuntuk mendapatkan nilai OR (Odds Ratio) terhadap variabel usia, pembiayaan, jenisHD, akses pembuluh darah, anemia, hipoalbuminemia, kelainan EKG, kardiomegali,komorbid, waktu rujukan ke nefrologis, dan kepatuhan. Prediktor yang bermakna kemudiandimasukkan pada model regresi logistik untuk mendapatkan sistem skor.Hasil dan Pembahasan. Sebanyak 78 (31,7%) dari 246 pasien meninggal dalam 3 bulanpertama. Terdapat 5 variabel yang berhubungan dengan terjadinya mortalitas 3 bulan yaituusia > 60 tahun, hemoglobin <8 g/dl, albumin serum <3,5 g/dl, kelainan EKG, dan aksesfemoral. Skor prediksi untuk prediktor usia, hemoglobin, albumin serum, kelainan EKG, danakses pembuluh darah berturut-turut sebesar 1, 3, 1, 3, 1. Jumlah skor kemudiandikategorikan menjadi risiko rendah (skor 0-3), sedang (skor 4-6), dan tinggi (skor 7-9). Tiapkelompok memiliki prediksi mortalitas 3 bulan berturut-turut sebesar 1,23%, 26,69%, dan86,04%.Kesimpulan. Insidens mortalitas 3 bulan pada pasien HD baru sebesar 31,7%. Usia > 60tahun, hemoglobin <8 g/dl, albumin serum <3,5 g/dl, kelainan EKG, dan akses femoralmerupakan prediktor yang bermakna terhadap terjadinya mortalitas dalam 3 bulan pertamaHD.

---

ABSTRACTBackground. Mortality risk among hemodialysis (HD) patients was known to be highest inthe first three months of dialysis. There were only limited data about the incidence andpredictors to this early death. A prediction model could be a simple tool to know high riskpatients to early death then the prevention efforts, as a final point, can be done.Aims. To determine the incidence and predictors for 3-month mortality among incidenthemodialysis patients and develop a prediction scoring system.Methods. A retrospective cohort study to 246 patients with End-Stage Renal Disease (ESRD)starting hemodialysis in Hemodialysis Unit of Cipto Mangunkusumo Hospital betweenJanuary 2011 and January 2012. The chi-square analysis was used to estimate Odds Ratio(OR) of age, payment, type of dialysis, femoral access, haemoglobin level, serum albuminlevel, abnormality of ECG, cardiomegaly by chest x-ray, comorbidity risk, time of referal tonephrologist, and adherence. Prediction score model was made for statistically significantfactors in logistic regression analysis.Results. Seventy-eight of 246 patients (31,7%) die within the first three months ofhemodialysis. There were 5 variables correlated to 3-month mortality included age >60 years,hemoglobin <8 g/dl, serum albumin <3,5 g/dl. The prediction score for those factors were 1,3, 1, 3, and 1, respectively. The total score then categorized the risk into low- (score 0-3),medium- (score 4-6), and high- (score 7-9) risk. The prediction of 3-months mortality foreach group were 1,23%, 26,69%, and 86,04% respectively.Conclusion. The incidence of 3-month mortality in incident hemodialysis patients was31,7%. Age >60 years, hemoglobin <8 g/dl, serum albumin <3,5 g/dl, abnormality of ECG,and femoral access were predictors to 3-months mortality."

"Latar Belakang: Seiiring dengan bertambahnya jumlah pasien diabetes melitus tipe 2 maka angka kejadian nefropati diabetik juga ikut meningkat. Berbagai faktor telah diidentifikasi turut memperberat kejadian nefropati diabetik salah satunya status vitamin D 25(OH)D. Vitamin D memiliki efek non-kalsemik yang dapat memengaruhi sistem renin-angiotensin sehingga turut berperan dalam kejadian albuminuria. Studi sebelumnya menunjukan tingginya prevalensi defisiensi vitamin D 25(OH)D pada pasien diabetes melitus tipe 2 dan defisiensi vitamin D diduga berhubungan dengan kejadian albuminuria. Tujuan: Mengetahui asosiasi antara status vitamin D 25(OH)D dengan albuminuria pada pasien diabetes melitus tipe 2 di Indonesia. Metodologi: Dilakukan studi potong lintang pada 96 pasien diabetes melitus tipe 2 yang berobat ke poliklinik Metabolik-Endokrin RSUPN-CM. Pemeriksaan kadar vitamin D 25(OH)D menggunakan kit Diasorin dengan metode CLIA dan albuminuria dinilai berdasarkan kadar albumin pada sampel urine sewaktu. Analisis bivariat menggunakan metode chi square dan analisis multivariat menggunakan teknik regresi logistik. Hasil: Prevalensi defisiensi vitamin D 25(OH)D pada pasien diabetes melitus tipe 2 sebesar 49% dengan nilai median kadar vitamin D 25(OH)D pada pasien diabetes melitus tipe 2 adalah 16,35 ng/mL (4,2-41,4 ng/mL). Tidak didapatkan adanya hubungan yang bermakna antara defisiensi vitamin D dengan albuminuria baik pada analisa bivariat maupun multivariat (OR 0,887;IK95% 0,335-2,296). Faktor perancu seperti kontrol gula darah yang buruk dan berat badan lebih sangat mempengaruhi hubungan antara defisiensi vitamin D dengan kejadian albuminuria pada pasien diabetes melitus tipe 2. Simpulan: Studi ini belum dapat menyimpulkan adanya hubungan antara defisiensi vitamin D 25(OH)D dengan albuminuria pada pasien diabetes melitus tipe 2 di Indonesia.

---

Background: In line with the increasing number of patients with diabetes mellitus type 2, the incidence of diabetic nephropathy is also increased. Various factors aggravating diabetic nephropathy have been identified, among others vitamin D 25(OH)D level. Vitamin D has a non-calcemic effect on renin-angiotensin system, causing albuminuria. Previous studies showed a high prevalence of vitamin D deficiency in patients with type 2 diabetes mellitus and it was related to the incidence of albuminuria.

Aim: To know the association between vitamin D 25(OH)D level with albuminuria in patients with type 2 diabetes mellitus in Indonesia.

Methods: A cross-sectional study was conducted in 96 patients with type 2 diabetes mellitus at outpatient clinic of Metabolic-Endocrine Cipto Mangunkusumo Hospital. Serum vitamin D level was assessed using Diasorin kit with CLIA method. Albuminuria was assessed using random urine sample. For bivariate analysis using chi square and multivariate analysis using regression logistic method.

Results: The prevalence of vitamin D 25(OH)D deficiency in patients with type 2 diabetes mellitus was 49% with a median value 16,35 ng / mL (4,2 - 41,4 ng /mL). There was no significant correlation between vitamin D deficiency with the severity of albuminuria (OR 0,887; 95% CI 0,335 to 2,296). Confounding factors such as poor blood glucose control and overweight strongly influenced the association between vitamin D deficiency with the incidence of albuminuria in patients with type 2 diabetes mellitus.

Conclusion: The results of this study have not been able to show an association between vitamin D deficiency with the severity of albuminuria in patients with type 2 diabetes mellitus in Indonesia."